research use only
Cat.No.S8877
| Related Targets | Dehydrogenase HSP Transferase P450 (e.g. CYP17) PDE phosphatase PPAR Vitamin Carbohydrate Metabolism Mitochondrial Metabolism |
|---|---|
| Other Ferroptosis Inhibitors | Liproxstatin-1 RSL3 Erastin Ferrostatin-1 (Fer-1) FIN56 iFSP1 UAMC-3203 SRS11-92 SRS16-86 icFSP1 |
| Cell Lines | Assay Type | Concentration | Incubation Time | Formulation | Activity Description | PMID |
|---|---|---|---|---|---|---|
| BJeLR | Growth inhibition assay | 48 hrs | Growth inhibition of human RAS-G12V overexpressing BJeLR cells after 48 hrs by alamar blue assay, IC50 = 0.003 μM. | 26231156 | ||
| CCF-STTG1 | Function assay | 2 hrs | Inhibition of Xct in human CCF-STTG1 cells assessed as glutamate release after 2 hrs by fluorometry, IC50 = 0.03 μM. | 26231156 | ||
| HT1080 | Growth inhibition assay | 48 hrs | Growth inhibition of human HT1080 cells after 48 hrs by alamar blue assay, GI50 = 0.314 μM. | 26231156 | ||
| DRD | Growth inhibition assay | 48 hrs | Growth inhibition of human RAS-G12V overexpressing DRD cells after 48 hrs by alamar blue assay | 26231156 | ||
| Click to View More Cell Line Experimental Data | ||||||
| Molecular Weight | 655.14 | Formula | C35H35ClN6O5 |
Storage (From the date of receipt) | 3 years -20°C powder |
|---|---|---|---|---|---|
| CAS No. | 1801530-11-9 | -- | Storage of Stock Solutions |
|
|
| Synonyms | PUN30119 | Smiles | CC(C)OC1=C(C=C(C=C1)C(=O)CN2C=CN=C2)N3C(=NC4=CC=CC=C4C3=O)CN5CCN(CC5)C(=O)COC6=CC=C(C=C6)Cl | ||
|
In vitro |
DMSO
: 100 mg/mL
(152.63 mM)
Ethanol : 100 mg/mL Water : Insoluble |
|
In vivo |
|||||
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
| Targets/IC50/Ki |
Ferroptosis
system xc–
|
|---|---|
| In vitro |
Imidazole Ketone Erastin (IKE) is an erastin analog with nanomolar potency, high metabolic stability, and intermediate water solubility. Its treatment potently reduces DLBCL cell number. |
References |
| Methods | Biomarkers | Images | PMID |
|---|---|---|---|
| Growth inhibition assay | Cell viability |
|
30799221 |
(data from https://clinicaltrials.gov, updated on 2024-05-22)
| NCT Number | Recruitment | Conditions | Sponsor/Collaborators | Start Date | Phases |
|---|---|---|---|---|---|
| NCT01555008 | Completed | Type 2 Diabetes Mellitus|Renal Impairment |
Lexicon Pharmaceuticals |
March 2012 | Phase 1 |
| NCT04545450 | Completed | Transgenderism|Hypogonadism |
Unita Complessa di Ostetricia e Ginecologia |
November 4 2008 | Phase 3 |
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.